The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD
Open accessAbstract
Central to the bone-sparing effect of estrogen (E 2 ) is its ability to block the monocytic production of the osteoclastogenic cytokine TNF-α (TNF).However, the mechanism by which E 2 downregulates TNF production is presently unknown.Transient transfection studies in HeLa cells, an E 2 receptor-negative line, suggest that E 2 inhibits TNF gene expression through an effect mediated by estrogen receptor β (ERβ).We also report that in RAW 264.7 cells, an E 2 receptor-positive murine monocytic line, E 2 downregulates cytokine-induced TNF gene expression by decreasing the activity of the Jun NH 2 -terminal kinase (JNK).The resulting diminished phosphorylation of c-Jun and JunD at their NH 2 -termini decreases the ability of these nuclear proteins to autostimulate the expression of the c-Jun and JunD genes, thus leading to lower production of c-Jun and JunD.The consequent decrease in the nuclear levels of c-Jun and JunD leads to diminished binding of c-Jun/c-Fos and JunD/c-Fos heterodimers to the AP-1 consensus sequence in the TNF promoter and, thus, to decreased transactivation of the TNF gene.J. Clin.Invest.104:503-513 (1999).Jun, Fos, and ATF (CREB) families of nuclear proteins (26).The Jun family consists of c-Jun, JunB, and JunD (26), and the Fos family includes c-Fos, Fra-1, Fra-2, FosB, and FosB2 (26).The presence of TRE sites in the TNF promoter, and the fact that AP-1 is known to be a critical inducer of human and murine TNF gene expression (27), suggests that E 2 could downregulate the production of TNF by decreasing the ability of AP-1 to transactivate the TNF promoter.In this study, we have investigated the effects of E 2 on cytokine-induced monocytic production of TNF.We report that E 2 downregulates cytokine-induced TNF gene expression by decreasing the activity of the Jun NH 2 -terminal kinase (JNK) through an effect that is likely mediated by ERβ.Decreased JNK activity results in blunted production of c-Jun and JunD, thus leading to decreased binding of c-Jun/Fos and JunD/Fos heterodimers to the AP-1 binding site in the TNF promoter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Cloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,788
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Conditions controlling the proliferation of haemopoietic stem cells in vitro
Dexter, T. M., Allen, T. D., & Lajtha, L. G. (1977) · Journal of Cellular Physiology · doi:10.1002/jcp.1040910303 · Cited by 2,066
Hibi, M., Lin, A., Smeal, T., Minden, A., & Karin, M. (1993) · Genes & Development · doi:10.1101/gad.7.11.2135 · Cited by 1,886
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789
Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,668
Signal transduction by the c-Jun N-terminal kinase (JNK) — from inflammation to development
Ip, Y. T., & Davis, R. J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80143-9 · Cited by 1,547
Whitmarsh, A. J., & Davis, R. J. (1996) · Journal of Molecular Medicine · doi:10.1007/s001090050063 · Cited by 1,543
Selective interaction of JNK protein kinase isoforms with transcription factors.
Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanagh, J., Sluss, H. K., Dérijard, B., & Davis, R. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00636.x · Cited by 1,338
The regulation of transcription by phosphorylation
Hunter, T., & Karin, M. (1992) · Cell · doi:10.1016/0092-8674(92)90162-6 · Cited by 1,281
An interleukin 1 like factor stimulates bone resorption in vitro
Gowen, M., Wood, D. D., Ihrie, E. J., McGuire, M. K. B., & Russell, R. G. G. (1983) · Nature · doi:10.1038/306378a0 · Cited by 1,012
Modulation of Osteoclast Differentiation
SUDA, T., TAKAHASHI, N., & MARTIN, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004
Couse, J. F., Lindzey, J., Grandien, K., Gustafsson, J.-A., & Korach, K. S. (1997) · Endocrinology · doi:10.1210/endo.138.11.5496 · Cited by 978
Shakhov, A. N., Collart, M. A., Vassalli, P., Nedospasov, S. A., & Jongeneel, C. V. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.1.35 · Cited by 819
Philip, R., & Epstein, L. B. (1986) · Nature · doi:10.1038/323086a0 · Cited by 767
Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
Pacifici, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110802 · Cited by 741
Self-citationProlonged activation of jun and collagenase genes by tumour necrosis factor-α
Brenner, D. A., O'Hara, M., Angel, P., Chojkier, M., & Karin, M. (1989) · Nature · doi:10.1038/337661a0 · Cited by 717
Repression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF-κB and C/EBPβ
Stein, B., & Yang, M. X. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4971 · Cited by 704
Webb, P. (1995) · Molecular Endocrinology · doi:10.1210/me.9.4.443 · Cited by 693
A simple method for site-directed mutagenesis using the polymerase chain reaction
Hemsley, A., Arnheim, N., Toney, M. D., Cortopassi, G., & Galas, D. J. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.16.6545 · Cited by 612
Pacifici, R., Brown, C., Puscheck, E., Friedrich, E., Slatopolsky, E., Maggio, D., McCracken, R., & Avioli, L. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5134 · Cited by 555
Self-citationRegulation and function of the JNK subgroup of MAP kinases
Minden, A., & Karin, M. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00018-8 · Cited by 484
Han, J., Brown, T., & Beutler, B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.2.465 · Cited by 477
Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.
Hall, C. V., Jacob, P. E., RINGOLD, G. M., & Lee, F. (1983) · PubMed · Cited by 472
Lipopolysaccharide Induction of the Tumor Necrosis Factor-α Promoter in Human Monocytic Cells
Yao, J., Mackman, N., Edgington, T. S., & Fan, S.-T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17795 · Cited by 457
Cytokines and Estrogen in Bone: Anti-Osteoporotic Effects
Horowitz, M. C. (1993) · Science · doi:10.1126/science.8480174 · Cited by 453
The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
Angel, P., & Karin, M. (1991) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(91)90011-9 · Cited by 450
The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties.
Tora, L., Mullick, A., Metzger, D., Ponglikitmongkol, M., Park, I., & Chambon, P. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03604.x · Cited by 417
Quinn, J. M. W., Elliott, J., Gillespie, M. T., & Martin, T. J. (1998) · Endocrinology · doi:10.1210/endo.139.10.6331 · Cited by 407
Transcriptional regulation in the immune system: all roads lead to AP-1
Foletta, V. C., Segal, D. H., & Cohen, D. R. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.2.139 · Cited by 390
Umayahara, Y., Kawamori, R., Watada, H., Imano, E., Iwama, N., Morishima, T., Yamasaki, Y., Kajimoto, Y., & Kamada, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34025-5 · Cited by 389
Bone marrow, cytokines, and bone remodeling
Manolagas, S. C. (1995) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(96)82696-5 · Cited by 387
Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.
Pacifici, R., Rifas, L., McCracken, R., Vered, I., McMurtry, C., Avioli, L. V., & Peck, W. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2398 · Cited by 375
Self-citationvan Dam, H., Duyndam, M., Rottier, R., Bosch, A., de Vries‐Smits, L., Herrlich, P., Zantema, A., Angel, P., & van der Eb, A. J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05680.x · Cited by 375 · cited 1×
“Similarly, E2 could repress p38, the kinase that, by phosphorylating ATF-2, contributes to the autoinduction of the c-Jun and JunD promoters (63).”
BackgroundKitazawa, R., Kimble, R. B., Vannice, J. L., Kung, V. T., & Pacifici, R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117606 · Cited by 336
Self-citationTumor Necrosis Factor: The molecules and Their Emerging Role in Medicine
Beutler, B., Han, J., Kruys, V., & Giroir, B. P. (1992) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 326
Ammann, P., Rizzoli, R., Bonjour, J. P., Bourrin, S., Meyer, J. M., Vassalli, P., & Garcia, I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119333 · Cited by 310
Westwick, J. K., Weitzel, C., Minden, A., Karin, M., & Brenner, D. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47207-9 · Cited by 293
Abu-Amer, Y., Ross, F. P., Edwards, J., & Teitelbaum, S. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119679 · Cited by 289
Self-citationLiu, Y., Gorospe, M., Yang, C., & Holbrook, N. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.15.8377 · Cited by 283
Tumor necrosis factor alpha -induced activation of c-jun N-terminal kinase is mediated by TRAF2
Reinhard, C. (1997) · The EMBO Journal · doi:10.1093/emboj/16.5.1080 · Cited by 276
Kimble, R. B., Srivastava, S., Ross, F. P., Matayoshi, A., & Pacifici, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28890 · Cited by 272
Self-citationTsai, J.-C., Jain, M., Hsieh, C.-M., Lee, W.-S., Yoshizumi, M., Patterson, C., Perrella, M. A., Cooke, C., Wang, H., Haber, E., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3667 · Cited by 243
The Functional Block of TNF but Not of IL-6 Prevents Bone Loss in Ovariectomized Mice
Kimble, R. B., Bain, S., & Pacifici, R. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.6.935 · Cited by 241 · cited 1×
“This evidence includes the finding that treatment with the TNF inhibitor TNF-binding protein completely prevents ovariectomy-induced bone loss (11) and the report that transgenic mice insensitive to TNF owing to the overexpression of a soluble TNF receptor are also protected against ovariectomy-induced bone loss (12).”
BackgroundSelf-citationRalston, S. H., Russell, R. G. G., & Gowen, M. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050912 · Cited by 231
Rhoades, K. L., Golub, S. H., & Economou, J. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41641-9 · Cited by 207
Srivastava, S., Weitzmann, M. N., Kimble, R. B., Rizzo, M., Zahner, M., Milbrandt, J., Ross, F. P., & Pacifici, R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4561 · Cited by 202
Self-citationSung, S. S., Bjorndahl, J. M., Wang, C. Y., Kao, H. T., & Fu, S. M. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.3.937 · Cited by 185
Molecular map of the murine S region.
Chaplin, D. D., Woods, D. E., Whitehead, A. S., Goldberger, G., Colten, H. R., & Seidman, J. G. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.22.6947 · Cited by 181
Ralston, S. H. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090614 · Cited by 174
Suda, T. (1992) · Endocrine Reviews · doi:10.1210/er.13.1.66 · Cited by 152
Estrogen receptor-β mRNA variants in human and murine tissues
Lu, B., Leygue, E., Dotzlaw, H., Murphy, L. J., Murphy, L. C., & Watson, P. H. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00050-1 · Cited by 146
Rifas, L., Kenney, J. S., Marcelli, M., Pacifici, R., Cheng, S., Dawson, L. L., & Avioli, L. V. (1995) · Endocrinology · doi:10.1210/endo.136.9.7649114 · Cited by 102
Self-citationCytokines and transcription factors
Muegge, K. (1990) · Cytokine · doi:10.1016/1043-4666(90)90036-s · Cited by 90
Dexter, T. M., Coutinho, L. H., Spooncer, E., Heyworth, C. M., Daniel, C. P., Schirò, R., Chang, J., & Allen, T. (2007) · Novartis Foundation symposium · doi:10.1002/9780470513880.ch6 · Cited by 82
Preferential activation of the p46 isoform of JNK/SAPK in mouse macrophages by TNFα
Chan, E. D., Winston, B. W., Jarpe, M. B., Wynes, M. W., & Riches, D. W. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13169 · Cited by 82
Shanker, G., Sorci‐Thomas, M. G., & Adams, M. R. (1994) · PubMed · Cited by 73
Jain, N. K., Mahendran, R., Philp, R. J., Guy, G. R., Tan, Y. H., & Cao, X. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13530 · Cited by 60
Wei, P. Y., Inamdar, N. M., & Vedeckis, W. V. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.9.0158 · Cited by 56
Beutler, B., & Brown, T. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115137 · Cited by 55
Schmitt, M., Bausero, P., Simoni, P., Queuche, D., Geoffroy, V., Marschal, C., Kempf, J., & Quirin‐Stricker, C. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490400203 · Cited by 44
Godambe, S. A., Chaplin, D., Takova, T., Read, L. M., & Bellone, C. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.112 · Cited by 25
Meyers, C. Y., Lutfi, H. G., & Adler, S. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00063-0 · Cited by 17
Self-citation
Cited by
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846
Estrogen deficiency and bone loss: an inflammatory tale
Weitzmann, M. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28550 · Cited by 990
Self-citationChanges in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914
The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation
Pavlov, V. A., Wang, H., Czura, C. J., Friedman, S. G., & Tracey, K. J. (2003) · Molecular Medicine · doi:10.1007/bf03402177 · Cited by 772
Metadata
- Authors
- Srivastava, S., Weitzmann, M. N., Cenci, S., Ross, F. P., Adler, S., & Pacifici, R.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-08-15
- Volume
- 104
- Issue
- 4
- Pages
- 503-513
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2157009361
- Cited by
- 255
- References
- 68
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.